KalVista Pharmaceuticals
KALV
KALV
110 hedge funds and large institutions have $567M invested in KalVista Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
28% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 25
51% less call options, than puts
Call options by funds: $2.45M | Put options by funds: $5.04M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
110
Holding in Top 10
–
Calls
$2.45M
Puts
$5.04M
Top Buyers
| 1 | +$37.9M | |
| 2 | +$27.4M | |
| 3 | +$19.4M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$6.84M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$5.54M |
Top Sellers
| 1 | -$19.3M | |
| 2 | -$16.9M | |
| 3 | -$13M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$6.65M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.21M |